MILLER, MS, C. J.; DART, MD, R. C.; KATZ, MD, MS, N. P.; WEBSTER, MD, FACPM, FASAM, L. R. Insights and issues from FDA Advisory Committee meetings on abuse-deterrent opioids. Journal of Opioid Management, [S. l.], v. 13, n. 6, p. 379–389, 2017. DOI: 10.5055/jom.2017.0416. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/764. Acesso em: 24 nov. 2024.